Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIR-EPO Study
2009-015511-40Phase 4Completed
- Sponsor
- Miguel Giovanni Uriol Rivera
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Epoetin alfa RB in anaemia, sponsored by Miguel Giovanni Uriol Rivera. Primary endpoints: Proportion of patients with stable hemoglobin after conversion and Mean change in hemoglobin between treatments. Started Sep 2009; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
anaemia
Beyond the preview
Go deeper on 2009-015511-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015511-40.